These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25266013)

  • 1. Molecular epidemiology of and genetic susceptibility to esophageal cancer.
    Bajpai M; Das KM; Lefferts J; Lisovsky M; Mashimo H; Phillips WA; Srivastava A; To H
    Ann N Y Acad Sci; 2014 Sep; 1325():40-8. PubMed ID: 25266013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational research on Barrett's esophagus.
    Baruah A; Buttar N; Chandra R; Chen X; Clemons NJ; Compare D; El-Rifai W; Gu J; Houchen CW; Koh SY; Li W; Nardone G; Phillips WA; Sharma A; Singh I; Upton MP; Vega KJ; Wu X
    Ann N Y Acad Sci; 2014 Sep; 1325():170-86. PubMed ID: 25266024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for prevention of cancers of the esophagus.
    Akiyama J; Alexandre L; Baruah A; Buttar N; Chandra R; Clark AB; Hart AR; Hawk E; Kandioler D; Kappel S; Krishnadath SK; Sharma A; Singh I; Straub D; Triadafilopoulos G; Umar A; Wolf B
    Ann N Y Acad Sci; 2014 Sep; 1325():108-26. PubMed ID: 25266020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial and early cancers of the esophagus.
    Davydov М; Delektorskaya VV; Kuvshinov YP; Lisovsky M; Pirogov SS; Udagawa H; Ueno M; Wang G
    Ann N Y Acad Sci; 2014 Sep; 1325():159-69. PubMed ID: 25266023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of esophageal dysplasia to cancer.
    Appelman HD; Matejcic M; Parker MI; Riddell RH; Salemme M; Swanson PE; Villanacci V
    Ann N Y Acad Sci; 2014 Sep; 1325():96-107. PubMed ID: 25266019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.
    Palles C; Findlay JM; Tomlinson I
    Adv Exp Med Biol; 2016; 908():265-90. PubMed ID: 27573776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign and precursor lesions in the esophagus.
    Akiyama J; Bertelé A; Brock C; Hvid-Jensen F; Ichiya T; Krarup AL; Majewski M; Rubio CA; Sarosiek J; Scarpignato C; Schmidt PT; Teich S; Triadafilopoulos G; Wallner G
    Ann N Y Acad Sci; 2014 Sep; 1325():226-41. PubMed ID: 25266028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Paulson TG
    Adv Exp Med Biol; 2016; 908():213-36. PubMed ID: 27573774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma.
    Ochs-Balcom HM; Falk G; Grady WM; Kinnard M; Willis J; Elston R; Eng C; Chak A
    Transl Res; 2007 Jul; 150(1):3-17. PubMed ID: 17585859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and esophageal disease.
    Dawsey SM; Fagundes RB; Jacobson BC; Kresty LA; Mallery SR; Paski S; van den Brandt PA
    Ann N Y Acad Sci; 2014 Sep; 1325():127-37. PubMed ID: 25266021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.
    Kalatskaya I
    Ann N Y Acad Sci; 2016 Oct; 1381(1):74-91. PubMed ID: 27415609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus: cancer and molecular biology.
    Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
    Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic analysis of esophageal cancers.
    Caygill CP; Gatenby PA; Herceg Z; Lima SC; Pinto LF; Watson A; Wu MS
    Ann N Y Acad Sci; 2014 Sep; 1325():69-76. PubMed ID: 25266016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
    Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL
    Nat Genet; 2013 Dec; 45(12):1487-93. PubMed ID: 24121790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.